Our data, combined with those of prior reports, suggest that Apoa4 deficiency may further aggravate metabolic dysfunction and oxidative stress, potentially dysregulating both pro- and anti-inflammatory responses in early obesity-related CKD. Here, APOA4 is linked to obesity due to melanocortin 4 receptor deficiency.